Reuters logo
BRIEF-Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan
April 17, 2017 / 12:07 PM / in 6 months

BRIEF-Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan

April 17 (Reuters) - Cleveland Biolabs Inc

* Cleveland Biolabs announces European Medicines Agency positive opinion regarding the entolimod pediatric investigation plan

* Cleveland Biolabs - EMA accepted co’s pediatric investigation plan paving way for submission of MAA for entolimod as medical radiation countermeasure Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below